National Bone Health Policy Institute Responds to Proposed Rules »

| Advocacy

NOF on behalf of the NBHPI has submitted comments to CMS and HHS regarding proposed rules that could impact osteoporosis patients access to testing and treatment. Comment letters have been submitted for the following: December 31, 2019 – Advance Notice of Proposed Rulemaking: International Price Index Model for Medicare Part B Drugs CMS-5528-ANPRM January 25,… Read more »

NOF Statement on Medicare Part B »

| Advocacy, NOF in the News

Washington, DC (October 25, 2018) – The National Osteoporosis Foundation issued the following statement regarding announced changes the Medicare Part B program: “Medicare Part B is vital to patients living with and managing chronic illnesses, like osteoporosis. Key to treatment under the program is the ability for doctors and patients to tailor care to the… Read more »

DXA Testing by the Numbers »

| Advocacy

Osteoporosis is under-diagnosed in the Medicare population according to a recent CDC NHANES survey. DXA scans are the gold standard for osteoporosis diagnosis, yet in 2007, CMS began significantly reducing reimbursement for DXA scans. This reduced the number of physicians in private offices offering DXA. As a result, fewer women and men were scanned resulting… Read more »

NOF Statement On Medicare Open Enrollment »

| Advocacy, NOF in the News, Press Releases

Patient Group Urges Fix To DXA Screening Reimbursement Rates To Encourage More Osteoporosis Screenings Today, as Medicare Open Enrollment starts, the National Osteoporosis Foundation (NOF) urged policymakers to raise the reimbursement rates for x-ray absorptiometry (DXA) screenings, which are the gold standard for osteoporosis screenings. Currently, bipartisan bills are sitting in both Chambers that would… Read more »

NOF Statement on Medicare Part D Cliff »

| Advocacy

Washington, DC  – The National Osteoporosis Foundation issued the following statement regarding the impending out-of-pocket cliff threatening the Medicare Part D program: “A looming threat to the Medicare Part D program is set to take effect in 2020 unless Congress takes action. The Part D cliff will significantly increase the catastrophic threshold – the amount… Read more »

NOF is Advocating for Increased Medicare Reimbursement for DXA Scans »

| Advocacy

Fractures related to osteoporosis threaten the health and independence of older Americans.  And fractures are common:  more than 2 million fractures happen each year due to osteoporosis.  The statistics are staggering and unnecessary. A DXA (Dual-energy X-ray absorptiometry) bone density test is a non-invasive, simple, yet top quality test for screening and diagnosing patients that… Read more »

NOF Statement on Medicare Part D »

| Advocacy, NOF in the News

Washington, DC – The National Osteoporosis Foundation (NOF) sent the following statement to Members of Congress on the importance of protecting Medicare Part D: NOF is concerned that recent changes to the Medicare Part D program in the Bipartisan Budget Act (BBA) of 2018 opens the door to other potentially harmful changes that could disrupt… Read more »

NOF Support for Issues of Importance to Osteoporosis Patients »

| Advocacy

NOF has been working hard on supporting issues of importance to osteoporosis patients by signing onto advocacy letters. Below you will be able to view and download letters we have signed onto: DXA Coalition Support Letter Medicare Community Statement LIS Co-Pay Letter SNAP Vitamin and Mineral Letter MassHealth Section 1115 Demonstration Amendment Request Medicare Access… Read more »

NOF Supporting the LIS Program »

| Advocacy

NOF has joined with other leading patient advocacy organizations on the national and state level to support the LIS program within Medicare Part D. NOF has signed on to the attached letters along with hundreds of other national and state-level organizations. To review them, please click on the letters below:    

NOF Response to S. 1688 Bill »

| Advocacy, NOF in the News

The National Osteoporosis Foundation (NOF), which recently led a letter to Congress signed by over 300 health advocacy groups opposing harmful government interference in the Medicare Part D program, today issued the following statement in response to S. 1688: “It is discouraging that, despite direct opposition from over 300 health advocates, members of Congress have… Read more »